Small Dense Low-Density Lipoprotein in Renal Transplant Recipients: A Potential Target for Prevention of Cardiovascular Complications?

Transplantation Proceedings

Volumn 38, Issue 7, 2006, Pages 2314-2316

  Badiou, S ^a   Garrigue, V ^a   Dupuy, A M ^a   Chong, G ^a   Cristol, J P ^a   Mourad, G ^a  

^a UNIV MONTPELLIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; APOLIPOPROTEIN C3; CYCLOSPORIN A; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; IMMUNOSUPPRESSIVE AGENT; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TACROLIMUS; TRIACYLGLYCEROL;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DYSLIPIDEMIA; FEMALE; GENOTYPE; GRAFT REJECTION; HUMAN; KIDNEY TRANSPLANTATION; LIPOPROTEIN METABOLISM; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PREVALENCE; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADULT; APOLIPOPROTEIN C-III; APOLIPOPROTEINS B; CARDIOVASCULAR DISEASES; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CYCLOSPORINE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; TACROLIMUS; TRIGLYCERIDES;

EID: 33846082301     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2006.07.003     Document Type: Article

References (9)

1. Satterthwaite R., Aswad S., and Sunga V. Incidence of new-onset hypercholesterolemia in renal transplant patients treated with FK506 or cyclosporine. Transplantation 65 (1998) 446
2. Holdaas H., Fellstrom B., and Jardine A.G. Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial. Lancet 361 (2003) 2024
3. Del C.D., Cruzado J.M., and Manel D.J. The effects of hyperlipidaemia on graft and patient outcome in renal transplantation. Nephrol Dial Transplant 19 (2004) 67
4. Packard C.J., and Sheperd J. Lipoprotein heterogeneity and apolipoprotein B metabolism. Arterioscler Thromb Vasc Biol 17 (1997) 3542
5. Vakkilainen J., Steiner G., and Ansquer J.C. Relationships between low-density lipoprotein particle size, plasma lipoproteins, and progression of coronary artery disease: the Diabetes Atherosclerosis Intervention Study (DAIS). Circulation 107 (2003) 1733
6. Tur M.D., Garrigue V., and Vela C. Apolipoprotein CIII is upregulated by anticalcineurins and rapamycin: implications in transplantation-induced dyslipidemia. Transplant Proc 32 (2000) 2783
7. Rodrigo E., Gonzalez-Lamuno D., and Ruiz J.C. Association between the SstI polymorphism of the apolipoprotein C-III gene, glucose intolerance and cardiovascular risk in renal transplant recipients. Transplant Proc 34 (2002) 379
8. Dallongeville J., Meirhaeghe A., and Cottel D. Gender related association between genetic variations of APOC-III gene and lipid and lipoprotein variables in northern France. Atherosclerosis 150 (2000) 149
9. Boizel R., Benhamou P.Y., and Lardy B. Ratio of triglycerides to HDL cholesterol is an indicator of LDL particle size in patients with type 2 diabetes and normal HDL cholesterol levels. Diabetes Care 11 (2000) 1679